Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine (2017)
- Authors:
- USP affiliated authors: KALIL FILHO, JORGE ELIAS - FM ; KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1128/JVI.00867-17
- Subjects: DENGUE; VACINAS; ANTICORPOS; VACINAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Título: Journal of virology
- ISSN: 0022-538X
- Volume/Número/Paginação/Ano: v. 91, n. 22, article ID UNSP e00867-17, 12p, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
MAGNANI, Diogo M. e KALIL FILHO, Jorge Elias e KALLÁS, Esper Georges. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of virology, v. 91, n. 22, 2017Tradução . . Disponível em: https://doi.org/10.1128/JVI.00867-17. Acesso em: 29 dez. 2025. -
APA
Magnani, D. M., Kalil Filho, J. E., & Kallás, E. G. (2017). Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of virology, 91( 22). doi:10.1128/JVI.00867-17 -
NLM
Magnani DM, Kalil Filho JE, Kallás EG. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine [Internet]. Journal of virology. 2017 ; 91( 22):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1128/JVI.00867-17 -
Vancouver
Magnani DM, Kalil Filho JE, Kallás EG. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine [Internet]. Journal of virology. 2017 ; 91( 22):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1128/JVI.00867-17 - CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children
- Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
- A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
- Short Communication: HIV Type 1 Subtype BF Leads to Faster CD4+ T Cell Loss Compared to Subtype B
Informações sobre o DOI: 10.1128/JVI.00867-17 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
